292
Views
11
CrossRef citations to date
0
Altmetric
Articles

Computer-aided design and discovery of protein–protein interaction inhibitors as agents for anti-HIV therapy

, , &
Pages 457-471 | Received 07 Oct 2013, Accepted 05 Jan 2014, Published online: 09 Apr 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Valentin Le Douce, Amina Ait-Amar, Faezeh Forouzan far, Faiza Fahmi, Jose Quiel, Hala El Mekdad, Fadoua Daouad, Céline Marban, Olivier Rohr & Christian Schwartz. (2016) Improving combination antiretroviral therapy by targeting HIV-1 gene transcription. Expert Opinion on Therapeutic Targets 20:11, pages 1311-1324.
Read now
P.V. Pogodin, A.A. Lagunin, D.A. Filimonov & V.V. Poroikov. (2015) PASS Targets: Ligand-based multi-target computational system based on a public data and naïve Bayes approach. SAR and QSAR in Environmental Research 26:10, pages 783-793.
Read now
Xiaoyu Qing, Xiao Yin Lee, Joren De Raeymaeker, Jeremy RH Tame, Kam YJ Zhang, Marc De Maeyer & Arnout RD Voet. (2014) Pharmacophore modeling: advances, limitations, and current utility in drug discovery. Journal of Receptor, Ligand and Channel Research 7, pages 81-92.
Read now

Articles from other publishers (8)

Khac-Minh Thai, Thai-Son Tran, The-Huan Tran, Thi-Cam-Nhung Cao, Hoang-Nhan Ho, Phuong Nguyen Hoai Huynh, Tan Thanh Mai, Thanh-Dao Tran, Minh-Tri Le & Van-Thanh Tran. 2023. Computational Modeling of Drugs Against Alzheimer’s Disease. Computational Modeling of Drugs Against Alzheimer’s Disease 231 277 .
Samuel K. Kwofie, Gabriel B. Kwarko, Emmanuel Broni, Michael B. Adinortey & Michael D. Wilson. 2022. Leishmaniasis - General Aspects of a Stigmatized Disease. Leishmaniasis - General Aspects of a Stigmatized Disease.
Chinmayee Choudhury & G. Narahari Sastry. 2019. Structural Bioinformatics: Applications in Preclinical Drug Discovery Process. Structural Bioinformatics: Applications in Preclinical Drug Discovery Process 25 53 .
Suyu Mei, Erik K. Flemington & Kun Zhang. (2018) Transferring knowledge of bacterial protein interaction networks to predict pathogen targeted human genes and immune signaling pathways: a case study on M. tuberculosis. BMC Genomics 19:1.
Crossref
S. P. Korolev, M. A. Pustovarova, A. M. Starosotnikov, M. A. Bastrakov, Yu. Yu. Agapkina, S. A. Shevelev & M. B. Gottikh. (2017) Nitrobenzofuroxane derivatives as dual action HIV-1 inhibitors. Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry 11:3, pages 286-290.
Crossref
S.P. Korolev, M.A. Pustovarova, A.M. Starosotnikov, M.A. Bastrakov, Yu.Yu. Agapkina, S.A. Shevelev & M.B. Gottikh. (2016) Nitrobenzofuroxane derivatives as dual action HIV-1 inhibitors. Biomeditsinskaya Khimiya 62:6, pages 725-728.
Crossref
Athina Geronikaki, Phaedra Eleftheriou & Vladimir Poroikov. 2018. Communicable Diseases of the Developing World. Communicable Diseases of the Developing World 37 95 .
Naruto Otawa, Tomoki Sumida, Hisashi Kitagaki, Kiyoyuki Sasaki, Shunsuke Fujibayashi, Mitsuru Takemoto, Takashi Nakamura, Tomohiro Yamada, Yoshihide Mori & Tomiharu Matsushita. (2015) Custom-made titanium devices as membranes for bone augmentation in implant treatment: Modeling accuracy of titanium products constructed with selective laser melting. Journal of Cranio-Maxillofacial Surgery 43:7, pages 1289-1295.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.